Elisabeth Formann

Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response

Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology · 2008 · 252 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Twice‐weekly administration of peginterferon‐<i>α</i>‐2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Elisabeth Formann, Wolfgang Jessner, Lawrence Bennett et al. · Journal of Viral Hepatitis · 2003 · 81 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Long‐term follow‐up of chronic hepatitis C patients with sustained virological response to various forms of interferon‐based anti‐viral therapy

Elisabeth Formann, Petra Steindl‐Munda, Heribert Hofer et al. · Alimentary Pharmacology & Therapeutics · 2006 · 77 citations

Medicine, Infectious Diseases, Internal Medicine +17

Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection

Judith H. Aberle, Elisabeth Formann, Petra Steindl‐Munda et al. · Journal of Clinical Virology · 2006 · 73 citations

Life Sciences, Immunology, Infectious Diseases +17

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

Péter Ferenci, Elisabeth Formann, Hermann Laferl et al. · Journal of Hepatology · 2005 · 68 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16